Table 1.

Characteristics of Epiretinal Membranes among 44 Consecutive Patients < 19 Years, 1976 through 2005

	Age	Gender	Eye	Etiology	Type	Management	Initial VA	Final VA	Changes in VA (Lines)
			OD			Followed
1	8	M		Traumatic	Unknown	Elsewhere	20/200	Unknown	Unknown
2	9	M	OD	Traumatic	None	Observation	20/100	20/20	8
3	10	M	OD	Traumatic	CMR	Observation	20/70	20/40	3
4	10	M	OD	Traumatic	Unknown	Observation	20/60	20/200	−6
5	11	M	OS	Traumatic	CMR	Observation	20/70	20/20	6
6	12	M	OS	Traumatic	None	Observation	20/30	20/25	1
			OD			Followed
7	12	M		Traumatic	Unknown	Elsewhere	20/40	Unknown	Unknown
8	14	M	OS	Traumatic	Unknown	Observation	20/400	20/200	3
			OD			Followed
9	15	M		Traumatic	None	Elsewhere	20/40	Unknown	Unknown
			OS			Followed
10	15	M		Traumatic	Unknown	Elsewhere	20/80	Unknown	Unknown
11	15	M	OS	Traumatic	Unknown	Observation	20/60	20/20	5
12	16	M	OD	Traumatic	Unknown	Observation	20/200	FC	Unknown
			OS			Followed
13	16	F		Traumatic	PMF	Elsewhere	20/25	Unknown	Unknown
14	16	M	OD	Traumatic	Unknown	Observation	20/300	20/300	1
15	16	M	OD	Traumatic	CMR	Observation	20/40	20/30	1
16	17	M	OD	Traumatic	Unknown	Observation	20/40	20/30	1
17	18	M	OD	Traumatic	Unknown	Observation	20/60	20/80	−2
18	1	F	OD	Idiopathic	PMF	PPV	Not Specified	20/40	Unknown
19	3	F	OD	Idiopathic	PMF	Observation	20/160	20/200	4
			OD			Followed
20	5	F		Idiopathic	Unknown	Elsewhere	20/250	Unknown	Unknown
21	5	F	OS	Idiopathic	PMF	Observation	20/40	20/25	2
22	5	M	OS	Idiopathic	PMF	PPV	20/125	20/100	1
23	8	F	OD	Idiopathic	Unknown	Observation	20/30	20/25	1
			OD			Followed
24	10	M		Idiopathic	CMR	Elsewhere	20/20	Unknown	Unknown
25	11	M	OS	Idiopathic	CMR	Observation	20/30	20/30	0
26	13	M	OS	Idiopathic	PMF	PPV	Not Specified	20/150	Unknown
27	15	M	OD	Idiopathic	Unknown	PPV	20/100	20/100	0
			OS			Followed
28	17	M		Idiopathic	CMR	Elsewhere	HM	Unknown	Unknown
			OS			Followed
29	18	M		Idiopathic	Unknown	Elsewhere	20/25	Unknown	Unknown
			OD		PMF	PPV	20/100	20/30	6
30	8	F	OS	Uveitic	PMF	PPV	20/150	20/60	5
			OD			Observation	20/20	20/25	−1
31	10	F	OS	Uveitic	Unknown		20/30	20/30	0
			OD		CMR		20/50	20/100	− 4
32	13	F	OS	Uveitic	PMF	Observation	20/80	20/100	− 1
			OD		PMF	Followed	20/20
33	13	M	OS	Uveitic	PMF	Elsewhere	20/250	Unknown	Unknown
34	16	M	OS	Uveitic	PMF	Observation	20/40	20/70	−3
35	16	M	OD	Uveitic	PMF	PPV	20/40	20/20	3
36	18	F	OS	Uveitic	Unknown	Observation	20/40	20/40	0
			OS			Followed
37	18	F		Uveitic	Unknown	Elsewhere	20/20	Unknown	Unknown
38	18	F	OS	Uveitic	PMF	PPV	20/100	20/20	8
			OD		PMF		LP	NLP
39	0	M	OS	Other	PMF	Observation	LP	FC	Unknown
			OD			Followed
40	12	F		Other	PMF	Elsewhere	20/50	Unknown	Unknown
41	8	M	OS	Other	PMF	PPV	20/400	Not Specified	Unknown
42	9	M	OD	Other	PMF	Observation	20/20	20/20	0
			OS			Followed
43	15	M		Other	Unknown	Elsewhere	20/70	Unknown	Unknown
44	15	M	OS	Other	PMF	Steroids	20/60	20/50	1

OD= right eye, OS = left eye

CMR= Cellophane Macular Reflex, PMF = Premacular Fibrosis

PPV = Pars Plana Vitrectomy

FC= Finger Counting, HM= Hand motion, LP= Light Perception, NLP= No Light Perception Change in VA - negative number signifies a decrease in visual acuity